As markets become more competitive and public and legislative scrutiny on healthcare costs increases, pharmaceutical companies must look for new ways to drive demand and sales. The commercialization process starts years before you’re ready to take a drug from the lab to the market. To secure your position in the market, innovative launch strategies, relationship building, and negotiations must start early.

 During this session, pharma industry expert, Jesse Mendelsohn, vice president, Model N, will share data-driven strategies to help you:

  • Establish and negotiate commercial contracts with payers and providers
  • Build and tune your European and overseas launch strategy
  • Make your product available to U.S. government health insurance programs including Medicaid and the VA

Success today requires you demonstrate value to patients, payers, and providers, all while adhering to increasing legislative and regulatory requirements. It all starts with robust commercialization plans that cover market demands, access, regulation, relationships, and global strategies.

Register today to learn more.

Featured Speaker

Jesse Mendelsohn

Vice President
Model N

An experienced life sciences executive, business analyst, and consultant, Jesse is an expert in pharmaceutical regulatory compliance and government pricing. Currently he manages Model N's services organization for life sciences, inclusive of 100+ consultants. As an industry thought leader, Jesse is often seen speaking at life sciences events and has authored multiple white papers and industry articles on government pricing and pharma regulation.



Now Available On-Demand